BioWin and MEDVIA sign first strategic collaboration between health clusters in Wallonia and Flanders The agreement will leverage strengths of two powerhouses dedicated to health to foster cross-border collaboration, building critical mass and consolidating sector to maintain Belgium’s position as a leader in Europe’s healthcare industry. Namur and Ghent, Belgium,…
After the launch of call 38 by BioWin, the NucleoGlio project emerged as a consortium between the coordinating company Belgian Volition SRL, in collaboration with QUALIblood SA, and the institutes UNamur-NARILIS and UCLouvain-IREC. Belgian Volition SRL, QUALIblood, UNamur and UCLouvain, working together as a consortium, have been granted EUR 2.2…
An extraordinary year for BioWin is coming to an end – a year full of significant milestones in our mission to accelerate innovation to meet tomorrow’s public health challenges and develop the knowledge, employment and competitiveness of all players in the health sector ecosystem. Review the best stories of 2023….
HealthTech Investor Summit connects European entrepreneurs and investors for the first time Bruges, Belgium, 16 November 2023 – The HealthTech Investor Summit in Bruges, Belgium, on 4-6 December is the first event to unite the European healthtech sector. This unique summit will bring together the largest group of healthtech investors…
Business Village Ecolys
Avenue d’Ecolys 2
5020 Namur (Belgium)
Email : contact@biowin.org
VAT BE 0882.768.591
Website by Monkeys not Donkeys
© 2024 BioWin.
